CCT020312 Exerts Anti-Prostate Cancer Effect by Inducing G1 Cell Cycle Arrest, Apoptosis and Autophagy through Activation of PERK/eIF2α/ATF4/CHOP Signaing

CCT020312 is a selective PERK activator and may have a potential anti-tumor effect. The authors iinvestigated the anti-prostate cancer effect and its underlying mechanism of CCT020312.